Exelixis
EXEL
#1790
Rank
$11.16 B
Marketcap
$41.47
Share price
-0.96%
Change (1 day)
17.91%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company